Literature DB >> 20806908

Caylobolide B, a macrolactone from symplostatin 1-producing marine cyanobacteria Phormidium spp. from Florida.

Lilibeth A Salvador1, Valerie J Paul, Hendrik Luesch.   

Abstract

A Phormidium spp. collection from Key West, Florida, afforded caylobolide B (1), an analogue of the known macrolactone caylobolide A, previously isolated from a Lyngbya majuscula collection from the Bahamas. The planar structure of 1 was determined using NMR and MS experiments. The relative configuration for subunits C7-C9 and C25-C29 was assigned using Kishi's Universal NMR Database. Caylobolide B (1) displayed cytotoxic activity against HT29 colorectal adenocarcinoma and HeLa cervical carcinoma cells with IC(50) values of 4.5 and 12.2 μM, respectively.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20806908      PMCID: PMC2965599          DOI: 10.1021/np100467d

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  12 in total

1.  Toward creation of a universal NMR database for stereochemical assignment: complete structure of the desertomycin/oasomycin class of natural products.

Authors:  Y Kobayashi; C H Tan; Y Kishi
Journal:  J Am Chem Soc       Date:  2001-03-07       Impact factor: 15.419

2.  Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1.

Authors:  H Luesch; R E Moore; V J Paul; S L Mooberry; T H Corbett
Journal:  J Nat Prod       Date:  2001-07       Impact factor: 4.050

3.  Structure and absolute stereochemistry of phormidolide, a new toxic metabolite from the marine cyanobacterium Phormidium sp.

Authors:  R Thomas Williamson; Anna Boulanger; Alexandra Vulpanovici; Mary A Roberts; William H Gerwick
Journal:  J Org Chem       Date:  2002-11-15       Impact factor: 4.354

4.  Tolytoxin and new scytophycins from three species of Scytonema.

Authors:  S Carmeli; R E Moore; G M Patterson
Journal:  J Nat Prod       Date:  1990 Nov-Dec       Impact factor: 4.050

5.  The molecular pharmacology of symplostatin 1: a new antimitotic dolastatin 10 analog.

Authors:  Susan L Mooberry; Rachel M Leal; Tina L Tinley; Hendrik Luesch; Richard E Moore; Thomas H Corbett
Journal:  Int J Cancer       Date:  2003-04-20       Impact factor: 7.396

Review 6.  Bioactive natural products from marine cyanobacteria for drug discovery.

Authors:  Lik Tong Tan
Journal:  Phytochemistry       Date:  2007-03-02       Impact factor: 4.072

7.  Caylobolide A, a unique 36-membered macrolactone from a Bahamian Lyngbya majuscula.

Authors:  John B MacMillan; Tadeusz F Molinski
Journal:  Org Lett       Date:  2002-05-02       Impact factor: 6.005

Review 8.  New peptides isolated from Lyngbya species: a review.

Authors:  Li Liu; Kathleen S Rein
Journal:  Mar Drugs       Date:  2010-06-09       Impact factor: 5.118

9.  Symplostatin 1: A dolastatin 10 analogue from the marine cyanobacterium Symploca hydnoides.

Authors:  G G Harrigan; H Luesch; W Y Yoshida; R E Moore; D G Nagle; V J Paul; S L Mooberry; T H Corbett; F A Valeriote
Journal:  J Nat Prod       Date:  1998-09       Impact factor: 4.050

10.  Long-range stereo-relay: relative and absolute configuration of 1,n-glycols from circular dichroism of liposomal porphyrin esters.

Authors:  John B MacMillan; Tadeusz F Molinski
Journal:  J Am Chem Soc       Date:  2004-08-18       Impact factor: 15.419

View more
  17 in total

1.  Targeted natural products discovery from marine cyanobacteria using combined phylogenetic and mass spectrometric evaluation.

Authors:  Lilibeth A Salvador-Reyes; Niclas Engene; Valerie J Paul; Hendrik Luesch
Journal:  J Nat Prod       Date:  2015-01-30       Impact factor: 4.050

2.  Amantelides A and B, Polyhydroxylated Macrolides with Differential Broad-Spectrum Cytotoxicity from a Guamanian Marine Cyanobacterium.

Authors:  Lilibeth A Salvador-Reyes; Jennifer Sneed; Valerie J Paul; Hendrik Luesch
Journal:  J Nat Prod       Date:  2015-07-23       Impact factor: 4.050

Review 3.  Therapeutic potential of marine peptides in cervical and ovarian cancers.

Authors:  Salman Ahmed; Haroon Khan; Sajad Fakhri; Michael Aschner; Wai San Cheang
Journal:  Mol Cell Biochem       Date:  2021-12-02       Impact factor: 3.396

Review 4.  Marine natural products targeting the eukaryotic cell membrane.

Authors:  Shinichi Nishimura
Journal:  J Antibiot (Tokyo)       Date:  2021-09-07       Impact factor: 2.649

5.  Total Synthesis of (-)-Bastimolide A: A Showcase for Type I Anion Relay Chemistry.

Authors:  Joshua B Cox; Alex A Kellum; Yiwen Zhang; Bo Li; Amos B Smith
Journal:  Angew Chem Int Ed Engl       Date:  2022-05-24       Impact factor: 16.823

6.  The Phormidolide Biosynthetic Gene Cluster: A trans-AT PKS Pathway Encoding a Toxic Macrocyclic Polyketide.

Authors:  Matthew J Bertin; Alexandra Vulpanovici; Emily A Monroe; Anton Korobeynikov; David H Sherman; Lena Gerwick; William H Gerwick
Journal:  Chembiochem       Date:  2015-12-23       Impact factor: 3.164

Review 7.  Recent advances and applications of experimental technologies in marine natural product research.

Authors:  Ke Li; Yu-Wen Chung-Davidson; Ugo Bussy; Weiming Li
Journal:  Mar Drugs       Date:  2015-04-29       Impact factor: 5.118

8.  Macrolactone Nuiapolide, Isolated from a Hawaiian Marine Cyanobacterium, Exhibits Anti-Chemotactic Activity.

Authors:  Shogo Mori; Howard Williams; Davey Cagle; Kristopher Karanovich; F David Horgen; Roger Smith; Coran M H Watanabe
Journal:  Mar Drugs       Date:  2015-10-09       Impact factor: 5.118

Review 9.  Marine cyanobacteria compounds with anticancer properties: a review on the implication of apoptosis.

Authors:  Margarida Costa; João Costa-Rodrigues; Maria Helena Fernandes; Piedade Barros; Vitor Vasconcelos; Rosário Martins
Journal:  Mar Drugs       Date:  2012-09-28       Impact factor: 6.085

10.  Fresh Water Cyanobacteria Geitlerinema sp. CCC728 and Arthrospira sp. CCC729 as an Anticancer Drug Resource.

Authors:  Akanksha Srivastava; Ratnakar Tiwari; Vikas Srivastava; Tej Bali Singh; Ravi Kumar Asthana
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.